U.S. Patient Access

Gilead Patient Support Programs

Our U.S. patient support programs help make Gilead therapies accessible for individuals who need information regarding insurance and financial support. These programs include:

Advancing Access®
Gilead HIV Treatment, HIV Prevention and COVID-19 Treatment
Phone: +1-800-226-2056  +1-800-226-2056 

Cayston Access Program®
Gilead Cystic Fibrosis Product
Phone: +1-877-722-9786  +1-877-722-9786 

Letairis Education and Access Program
Gilead Pulmonary Arterial Hypertension (PAH)
Phone: +1-866-664-5327  +1-866-664-5327

Support Path®
Gilead Hepatitis B and C
Phone: +1-855-769-7284 +1-855-769-7284

Zydelig® AccessConnect
Gilead Oncology
Phone: +1-844-622-2377 +1-844-622-2377

Kite Konnect
Kite Oncology
Phone: +1-844-454-KITE (5483). +1-844-454-KITE (5483)

The integrity of our patient support programs is critical to their sustainability. Any concerns about potential fraudulent activity involving patient support programs can be reported here.

Advancing Access®

Gilead’s Advancing Access program helps patients understand their coverage and identify financial support options to access their Gilead HIV treatment, HIV prevention medication and COVID-19 medication. The program offerings include:

  • Access to program specialists who can help answer insurance-related questions and provide information regarding coverage options.
  • Advancing Access co-pay coupon program, which provides co-pay support for eligible people on HIV treatment and HIV prevention medication with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $0 per month. The co-pay coupon program is not available for people enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Medicare Part D enrollees in the coverage gap (also known as the "donut hole") also are not eligible. Additional restrictions may apply.
  • Advancing Access patient assistance program, which provides Gilead medicines at no cost for qualified patients who meet the program’s eligibility criteria.
  • We recognize that hospital systems have established ways to support patients in the hospital with reimbursement and payment-related concerns. Advancing Access can support those efforts by:

    • Providing information and education about support that may be available to hospitals treating patients with Veklury® through the Advancing Access Veklury® (remdesivir) Resource Call Center.
    • Responding to general questions and inquiries from facilities, healthcare providers, and patients regarding Veklury and product accessibility.
    • Offering education on available resources for hospitals and/or patients (e.g. Medicaid/Medicare, CARES Act, etc.).
    • Providing coding and reimbursement information.

    The Advancing Access program supports the following medicines:

    • Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide)
    • Complera® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
    • Descovy® (emtricitabine/tenofovir alafenamide)
    • Emtriva® (emtricitabine)
    • Genvoya® (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide)
    • Odefsey® (emtricitabine/rilpivirine/tenofovir alafenamide)
    • Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate)
    • Truvada® (emtricitabine/tenofovir disoproxil fumarate)
    • Tybost® (cobicistat)
    • Veklury® (remdesivir)

    To learn more about the Advancing Access program, visit www.GileadAdvancingAccess.com or call 1-800-226-2056, Monday through Friday between 9 a.m. and 8 p.m. EST.

Cayston Access Program®

The Cayston Access Program helps patients understand their coverage and identify financial support options to access Cayston® (aztreonam for inhalation solution). The program offerings include:

  • Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
  • Information about authorized distributors (i.e. participating specialty pharmacies).
  • Cayston co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $10 per month. The co-pay coupon program is not available for patients enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Medicare Part D enrollees in the coverage gap (also known as the "donut hole") also are not eligible. Additional restrictions may apply.
  • Referral to the Cayston patient assistance program, which provides Cayston at no cost for qualified patients who meet the program’s eligibility criteria.

To learn more about the Cayston Access Program, visit https://www.cayston.com/ or call 1-877-7CAYSTON (877-722-9786) (877-722-9786), Monday through Friday between 8 a.m. and 8 p.m. EST.

Letairis Education and Access Program

The Letairis Education and Access Program (LEAP) helps patients understand their coverage and identify financial support options to access Letairis® (ambrisentan). The program offerings include:

  • Access to case managers who can help answer insurance-related questions and provide information regarding coverage options.
  • Information about authorized distributors (i.e. participating specialty pharmacies).
  • Letairis co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $5 per month. The co-pay coupon program is not available for patients enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Medicare Part D enrollees in the coverage gap (also known as the "donut hole") also are not eligible. Additional restrictions may apply.
  • Referral to the Patient Assistance Solutions™ program, which provides Letairis at no cost for qualified patients who meet the program’s eligibility criteria.

To learn more about LEAP, visit https://www.letairis.com/patients/ or call 1-866-664-5327 1-866-664-5327, Monday through Friday between 8 a.m. and 8 p.m. EST.

Support Path®

The Support Path program helps patients understand their coverage and identify financial support options to access their Gilead HCV and HBV medicines. The program offerings include:

  • Access to program navigators who can help answer insurance-related information and provide questions regarding coverage options.
  • Access to a nursing support line.
  • Gilead HCV and HBV co-pay coupon programs, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $5 per month. The co-pay coupon program is not available for patients enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Medicare Part D enrollees in the coverage gap (also known as the "donut hole") also are not eligible. Additional restrictions may apply.
  • Support Path patient assistance program, which provides Gilead HCV and HBV medicines at no cost for qualified patients who meet the program’s eligibility criteria.

The Support Path program supports the following medicines:

  • Epclusa® (sofosbuvir/velpatasvir)
  • Harvoni® (ledipasvir/sofosbuvir)
  • Sovaldi® (sofosbuvir)
  • Vosevi® (sofosbuvir/velpatasvir/voxilaprevir)
  • Vemlidy® (tenofovir alafenamide)

To learn more about Support Path, visit https://www.mysupportpath.com or call 1 855 769 7284 1-855-769-7284, Monday through Friday between 9 a.m. and 8 p.m. EST.

Zydelig® AccessConnect™

The Zydelig AccessConnect program helps patients understand their coverage and identify financial support options to access Zydelig® (idelalisib). The program offerings include:

  • Access to case managers to help answer insurance-related questions and provide information regarding coverage options.
  • Information about authorized distributors (i.e. participating specialty pharmacies).
  • Zydelig co-pay coupon program, which provides co-pay support for eligible patients with commercial insurance who need help paying for their out-of-pocket medicine costs. Eligible patients could pay as little as $5 per month. The co-pay coupon program is not available for patients enrolled in government healthcare prescription drug programs, such as Medicare Part D and Medicaid. Medicare Part D enrollees in the coverage gap (also known as the "donut hole") also are not eligible. Additional restrictions may apply.
  • Zydelig QuickStart program, which provides a 30-day supply of medicine at no cost for qualified patients who are experiencing insurance coverage delays (restrictions apply).
  • Referral to the Zydelig patient assistance program, which provides Zydelig at no cost for qualified patients who meet the program’s eligibility criteria.

To learn more about Zydelig AccessConnect, visit www.zydeligaccessconnect.com or call 1-844-6ACCESS (1-844-622-2377) 1-844-6ACCESS (1-844-622-2377) between 8 a.m. and 8 p.m. EST.

Kite Konnect™

Kite Konnect™ is committed to helping patients and healthcare teams throughout treatment with CAR T-cell therapy, including:

  • Patient enrollment
  • Reimbursement support
  • Logistics support

Visit KiteKonnect.com